Pulmonary embolism / Paul D. Stein
- Author
- Stein, Paul D.
- Published
- Chichester, West Sussex, UK ; Hoboken, NJ : John Wiley & Sons Inc., [2016]
- Edition
- 3rd edition.
- Physical Description
- 1 online resource
Access Online
- Contents
- Machine generated contents note: 1.Pulmonary embolism and deep venous thrombosis at autopsy -- 2.Incidence of pulmonary embolism and deep venous thrombosis in hospitalized patients and in emergency departments -- 3.Case fatality rate and population mortality rate from pulmonary embolism and deep venous thrombosis -- 4.Prognosis in acute pulmonary embolism based on right ventricular enlargement and biochemical markers in stable patients -- 5.Prognosis in acute pulmonary embolism based on scoring systems -- 6.Pulmonary embolism following deep venous thrombosis and outcome with untreated pulmonary embolism -- 7.Resolution of pulmonary embolism -- 8.Upper extremity deep venous thrombosis -- 9.Thromboembolic disease involving the superior vena cava and brachiocephalic veins -- 10.Venous thromboembolic disease in the four seasons -- 11.Regional differences in the United States of rates of diagnosis of pulmonary embolism and deep venous thrombosis and mortality from pulmonary embolism -- 12.Venous thromboembolism according to age and in the elderly -- 13.Pulmonary thromboembolism in infants and children -- 14.Venous thromboembolism in men and women -- 15.Pulmonary embolism and deep venous thrombosis in blacks and whites -- 16.Pulmonary thromboembolism in Asians/Pacific Islanders -- 17.Pulmonary thromboembolism in American Indians and Alaskan Natives -- 18.Venous thromboembolism in patients with cancer -- 19.Venous thromboembolism in patients with heart failure -- 20.Obesity as a risk factor in venous thromboembolism -- 21.Hypertension, smoking, and cholesterol -- 22.Overlap of venous and arterial thrombosis risk factors -- 23.Venous thromboembolism in patients with ischemic and hemorrhagic stroke -- 24.Paradoxical embolism -- 25.Pulmonary embolism and deep venous thrombosis in hospitalized adults with chronic obstructive pulmonary disease -- 26.Pulmonary embolism and deep venous thrombosis in hospitalized patients with asthma -- 27.Deep venous thrombosis and pulmonary embolism in hospitalized patients with sickle cell disease -- 28.Diabetes mellitus and risk of venous thromboembolism -- 29.Risk of venous thromboembolism with rheumatoid arthritis -- 30.Venous thromboembolism with inflammatory bowel disease -- 31.Venous thromboembolism with chronic liver disease -- 32.Nephrotic syndrome -- 33.Human immunodeficiency virus infection -- 34.Venous thromboembolism in pregnancy -- 35.Amniotic fluid embolism -- 36.Air travel as a risk for pulmonary embolism and deep venous thrombosis -- 37.Estrogen-containing oral contraceptives and venous thromboembolism -- 38.Estrogen and testosterone in men -- 39.Tamoxifen -- 40.Venous thromboembolism following bariatric surgery -- 41.Hypercoagulable syndrome -- 42.Deep venous thrombosis of the lower extremities: clinical evaluation -- 43.Clinical scoring system for assessment of deep venous thrombosis -- 44.Clinical probability score plus single negative ultrasound for exclusion of deep venous thrombosis -- 45.D-dimer for the exclusion of acute deep venous thrombosis -- 46.D-dimer combined with clinical probability assessment for exclusion of acute deep venous thrombosis -- 47.D-dimer and single negative compression ultrasound for exclusion of deep venous thrombosis -- 48.Contrast venography -- 49.Compression ultrasound for the diagnosis of deep venous thrombosis -- 50.Impedance plethysmography and fibrinogen uptake tests for diagnosis of deep venous thrombosis -- 51.Ascending CT venography and venous phase CT venography for diagnosis of deep venous thrombosis -- 52.Magnetic resonance venography for diagnosis of deep venous thrombosis -- 53.P-selectin and microparticles to predict deep venous thrombosis -- 54.Clinical characteristics of patients with no prior cardiopulmonary disease -- 55.Relation of right-sided pressures to clinical characteristics of patients with no prior cardiopulmonary disease -- 56.The history and physical examination in all patients irrespective of prior cardiopulmonary disease -- 57.Clinical characteristics of patients with acute pulmonary embolism stratified according to their presenting syndromes -- 58.Clinical assessment in the critically ill -- 59.The electrocardiogram -- 60.The plain chest radiograph -- 61.Arterial blood gases and the alveolar-arterial oxygen difference in acute pulmonary embolism -- 62.Fever in acute pulmonary embolism -- 63.Leukocytosis in acute pulmonary embolism -- 64.Alveolar dead-space in the diagnosis of pulmonary embolism -- 65.Empirical assessment and clinical models for diagnosis of acute pulmonary embolism -- 66.Prognostic models for pulmonary embolism -- 67.D-dimer for the exclusion of acute pulmonary embolism -- 68.D-dimer combined with clinical probability for exclusion of acute pulmonary embolism -- 69.D-dimer in combination with amino-terminal pro-B-type natriuretic peptide for exclusion of acute pulmonary embolism -- 70.Tissue plasminogen activator, plasminogen activator inhibitor-1, and thrombin -antithrombin III complexes in the exclusion of acute pulmonary embolism -- 71.Echocardiogram in the diagnosis of acute pulmonary embolism -- 72.Trends in the use of diagnostic imaging in patients hospitalized with acute pulmonary embolism -- 73.Techniques of perfusion and ventilation imaging -- 74.Ventilation- perfusion lung scan criteria for interpretation prior to the Prospective Investigation of Pulmonary Embolism Diagnosis (PIOPED) -- 75.Observations from PIOPED: ventilation- perfusion lung scans alone and in combination with clinical assessment -- 76.Ventilation- perfusion lung scans according to complexity of lung disease -- 77.Perfusion lung scans alone in acute pulmonary embolism -- 78.Probability interpretation of ventilation-perfusion lung scans in relation to the largest pulmonary arterial branches in which pulmonary embolism is observed -- 79.Revised criteria for evaluation of lung scans recommended by nuclear physicians in PIOPED -- 80.Criteria for very-low-probability interpretation of ventilation - perfusion lung scans -- 81.Probability assessment based on the number of mismatched segmental equivalent perfusion defects -- 82.Probability assessment based on the number of mismatched vascular defects and stratification according to prior cardiopulmonary disease -- 83.The addition of clinical assessment to stratification according to prior cardiopulmonary disease further optimizes the interpretation of ventilation-perfusion lung scans -- 84.Pulmonary scintigraphy scans since PIOPED -- 85.Single photon emission computed tomographic (SPECT) lung scans -- 86.SPECT with radiolabeled markers -- 87.Standard and augmented techniques in pulmonary angiography -- 88.Subsegmental pulmonary embolism -- 89.Quantification of pulmonary embolism by conventional and CT angiography -- 90.Complications of pulmonary angiography -- 91.Contrast-enhanced spiral CT for the diagnosis of acute pulmonary embolism before the Prospective Investigation of Pulmonary Embolism Diagnosis II -- 92.Methods of PIOPED II -- 93.Multidetector spiral CT of the chest for acute pulmonary embolism: results of the PIOPED II trial -- 94.Multidetector CT pulmonary angiography since PIOPED II -- 95.Outcome studies of pulmonary embolism versus accuracy -- 96.Contrast-induced nephropathy -- 97.Radiation exposure and risk -- 98.Magnetic resonance angiography for the diagnosis of acute pulmonary embolism -- 99.Serial noninvasive leg tests in patients with suspected pulmonary embolism -- 100.Diagnosis of pulmonary embolism in the coronary care unit -- 101.Silent pulmonary embolism with deep venous thrombosis -- 102.Fat embolism syndrome -- 103.Diagnostic approach to acute pulmonary embolism -- 104.Warfarin and other vitamin K antagonists -- 105.Unfractionated heparin, low-molecular-weight heparin, heparinoid, and pentasaccharide -- 106.Parenteral inhibitors of factors Va, VIIIa, tissue factor, and thrombin -- 107.Novel oral anticoagulants -- 108.Aspirin for venous thromboembolism -- 109.Immediate therapeutic levels of heparin in relation to timing of recurrent events -- 110.Intermittent pneumatic compression -- 111.Graduated compression stockings -- 112.Ankle exercise and venous blood velocity -- 113.Thrombolytic therapy for deep venous thrombosis -- 114.Mechanical and ultrasonic enhancement of catheter-directed thrombolytic therapy for deep venous thrombosis -- 115.Thrombolytic therapy for treatment of acute pulmonary embolism -- 116.Catheter-tip embolectomy in the management of acute massive pulmonary embolism -- 117.Vena cava filters -- 118.Withholding treatment of patients with acute pulmonary embolism who have a high risk of bleeding provided and negative serial noninvasive leg tests -- 119.Home treatment of deep venous thrombosis -- 120.Home treatment of acute pulmonary embolism -- 121.Pulmonary embolectomy -- 122.Chronic thromboembolic pulmonary hypertension and pulmonary thromboendarterectomy -- 123.Prevention and treatment of deep venous thrombosis and acute pulmonary embolism: American College of Chest Physicians Guidelines.
- Summary
- Pulmonary embolism (PE) is the third most common acute cardiovascular disease after acute yocardial infarction and stroke. This fully updated third edition supplies the latest information on epidemiology, methods of diagnosis, preferred diagnostic pathways, new medications including the new anticoagulants, and new recommendations for prophylaxis and treatment of pulmonary embolism and its immediate cause, deep vein thrombosis. --
An essential and comprehensive resource for physicians and allied professionals in the field of this difficult-to-diagnose and life threatening condition --
Highly illustrated with numerous tables and graphs alongside clear concise text --
Includes chapters addressing pulmonary embolism (PE) and deep venous thrombosis (DVT) in relation to diseases and disorders such as chronic heart failure, cancer, diabetes, stroke, chronic obstructive pulmonary disease (COPD) and many more --
Discusses the role the different tools in imaging for PE, including, echocardiography, multidetector computed tomography (CT), single photon emission computed tomography (SPECT), ventilation-perfusion (V-Q) imaging, dual energy CT, and magnetic resonance angiography --
Contains 29 new chapters and includes new content on epidemiology of deep venous thrombosis; use of the new anticoagulants (dabigatran, rivaroxaban, and apixaban) for DVT and PE, indications and results with thrombolytic therapy and with vena cava filters, and information and indications for invasive mechanical thrombectomy --
Written by an internationally recognized and respected expert in the field --Book Jacket. - Subject(s)
- ISBN
- 9781119039099 (Adobe PDF)
1119039096 (Adobe PDF)
9781119039105 (ePub)
111903910X (ePub)
9781119039082 (cloth)
9781119039112
1119039118
1119039088 (cloth) - Bibliography Note
- Includes bibliographical references and index.
View MARC record | catkey: 19159828